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Objective: Metabolomic profiling of seminal plasma has been suggested as a possible approach for a fast
and non-invasive male infertility evaluation diagnosis. However, metabolomics profiles in normo-
zoospermic men have not been thoroughly investigated, and the influence of ejaculation-abstinence
has not been described.
To provide interim reference values and find associations between the metabolomics profiles of human
seminal plasma and length of ejaculation-abstinence period in normozoospermic men.
Study design: Semen samples collected after long (4–7 days) and short abstinence (2 h) from 31 normo-
zoospermic males were assessed for routine quality parameters before the seminal plasma was separated
by centrifugation. Metabolomics profiles of the seminal plasma were then determined using untargeted
Nuclear Magnetic Resonance Spectroscopy.
Results: In total, 30 metabolites were identified. Pyruvate showed a higher concentration, while fructose,
acetate, choline, methanol, N-acetylglucosamine, O-acetylcarnitine, uridine, and sn-glycero-3-
phosphocoline showed lower concentrations in samples collected after short abstinence (vs. long). All
metabolites showed lower absolute amounts (volume  concentration) following shorter abstinence.
However, the lower sperm concentration in samples collected after short abstinence resulted in higher
absolute amounts of pyruvate and taurine per spermatozoa: pyruvate 1.92 (1.12–3.87) vs. 1.29 (0.83–
2.62) (P < 0.001) and taurine 0.58 (0.36–0.92) vs. 0.43 (0.28–0.95) (P < 0.05) ng/106 spermatozoa.
Simultaneously, there was a higher percentage of progressively motile spermatozoa in samples collected
after the short abstinence.
Conclusion: The generally lower concentrations of seminal metabolites after short abstinence periods may
be related to the shorter time available for secretion and collection of these metabolites by the accessory
glands and the epididymides. The concomitant lower number of spermatozoa in the second ejaculate
resulted in increased absolute amounts of pyruvate and taurine per spermatozoa, accompanied by
increased spermatozoa motility in these samples.
The simultaneous increase in percentages of motile spermatozoa and absolute amounts of pyruvate and
taurine per spermatozoa after shorter abstinence might indicate that these two metabolites play a more
critical role in sperm motility, which should be further investigated in future studies.
 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).rm Class
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Male-factor infertility contributes to almost half of the cases
with couples’ infertility [1]. Investigations of infertile men focus
on assessing classical parameters like sperm concentration, motil-
ity, and morphology. Assessment of seminal plasma is only done in
severe cases where the concentration of accessory glands secre-
tions (e.g. fructose, citric acid, a-glucosidase or zinc) are measured
to assess their function [2].
In humans, seminal plasma (HSP) does not progress beyond the
external cervix [3], and it is considered the nutritious and protein-
rich environment needed for spermatozoa to function [4]. How-
ever, HSP may affect the fertilization ability and even successful
implantation and pregnancy outcomes [3]. The multifocal origin
of seminal plasma (~65% from the seminal vesicles, ~25% from
the prostate and ~10% from testes and epididymides, and ~1% from
the bulbourethral and periurethral glands) has complicated the
search for biomarkers in this fluid [5].
Identifying the metabolome may improve our understanding of
cells’ normal composition, physiology, and dysfunction [6-9]. Spec-
trometric and chromatographic methods can be used to assess
metabolomic profiles [10,11]. The non-destructive, non-selective,
non-biased, quantitative ability to identify novel compounds via
their unique spectral patterns has made Nuclear Magnetic Reso-
nance (NMR) spectroscopy a particularly appealing tool for meta-
bolomics [12].
In contrast to less than 100 metabolites, over 6000 proteins in
the human spermatozoa (about 80% of this cell’s estimated pro-
teome) have been identified[13]. In general, humans have a much
lower number of metabolites than proteins [8,14]. Despite the
notable developments in metabolomics technology, the relatively
lower number of metabolites identified in sperm and HSP may
be because the ’omics’ techniques have not been applied to their
full potential in this field [4,6,13].
Nonetheless, metabolomic profiling of seminal plasma has been
suggested as a possible approach for a fast and non-invasive diag-
nosis in the evaluation of male infertility [7,15-17]. Studies assess-
ing HSP metabolomics profiling by LC-MS/MS as a screening tool
for male infertility demonstrated a correlation between HSP
metabolites and sperm concentration and morphology [18]. NMR
profiling of HSP metabolites combined with Principal Component
Analysis (PCA) has been able to differentiate semen quality and
classify patients with leukocytospermia, varicocele, testicular can-
cer, necrozoospermia, azoospermia [19], and oligoasthenoterato-
zospermia [20]. A more recent comparative study using 1H NMR
could not classify teratozoospermia index (TZI) using HSP metabo-
lite profiling in fertile and teratozoospermia patients [21].
A gap in our knowledge regarding HSP metabolites and their
impact on semen quality and function still exists. Namely, changes
in HSP metabolomics profile following different abstinence periods
in the same person have not been yet determined. Therefore, this
exploratory study focused on characterizing and comparing the
HSP metabolomics profile in two consecutive ejaculates collected
from normozoospermic males after long (4–7 days) followed by a
short (2 h) ejaculation-abstinence period to provide interim ref-
erence values and find associations between the metabolomics
profiles of human seminal plasma and length of ejaculation absti-
nence period in normozoospermic men.Materials and methods
Ethical approval
The samples were collected at Dronninglund Fertility Clinic
(Aalborg University Hospital) following approval by the scientific179ethics committee of the North Jutland Region, Denmark (approval
number N-20140023). Informed written consent was obtained
from all subjects, and the study was performed in accordance with
the Declaration of Helsinki as revised in Tokyo 2004.
Study subjects
The study group consisted of thirty-one male partners from
couples undergoing in-vitro fertilization (IVF) or intra-
cytoplasmic sperm injection (ICSI) regardless of the etiology. Their
median (Interquartile range (IQR)) age was 33.5 (30–39) years, and
median body mass index (BMI) was 26.5 (23.5–28.3). To not inter-
fere with the treatment process on the day of the study, only men
with a minimum sperm concentration of 15 million/ml (WHO ref-
erence value) in the first ejaculate were included in the study. Par-
ticipants were without a medical history of vasectomy, orchitis,
unilateral orchiectomy, ejaculatory disorders, diabetes, cardiovas-
cular disease, medically treated psychological illness, endocrine,
or genetic diseases.
Sample collection
All participants had an ejaculation-abstinence period of 4–
7 days (median (IQR) of 6 (5–7) days) before delivering the semen
sample for IVF/ICSI treatment. The second semen sample was
delivered 2 h after the first. All samples were obtained by mastur-
bation into a wide-mouthed plastic container and allowed to liq-
uefy (~60 min) at room temperature. Semen volume was
measured using a graduated pipette, and 1000 mL from each sam-
ple was used for seminal plasma collection.
Semen analysis, Sperm Class Analyzer (SCA)
The Motility/Concentration module of the SCA (version 5.4;
Microptic S.L., Barcelona, Spain) connected to a Basler Scout
A780–54fc camera (Basler, Germany) capturing at 50fps, mounted
on a Nikon Eclipse 50i microscope with a 10x positive phase con-
trast lens (Nikon, Japan) was used to determine sperm concentra-
tion and progressive motility as previously described [22]. Five
different fields along the middle of a Leja 10 (Leja, Netherlands)
slide loaded with 2 mL of well-mixed neat semen were evaluated
for each sample to detect and compensate for any possible non-
uniform distribution of spermatozoa in the chamber [23]. Sperma-
tozoa were classified as progressively motile, non-progressive
motile or immotile [24]. Sperm morphology was assessed using
the morphology module of the SCAas previously described [25].
Nuclear magnetic resonance spectroscopy
After liquefaction, 1 ml of the semen sample was centrifuged at
3000g for 20 min at 4 C to separate the seminal plasma from the
sperm. The top 500 mL of the supernatant was collected and imme-
diately frozen in sterile Eppendorf tubes (Eppendorf, USA) at
80 C. Frozen samples were thawed slowly on ice (~ 10 min)
and centrifuged at 12,100g for 30 min to remove the remaining
cell debris. The supernatant collected from each sample was vor-
texed for 10 s. 100 lL of supernatant was added to 420 lL D2O
and 60 lL 0.5 M phosphate buffer pH 7 containing 0.23 M TSP-d4
(sodium-3-trimethylsilyl-[2,2,3,3-2H4]-propionate) and 20 mM
NaN3. Subsequently, pH was adjusted to 7.0 ± 0.1 using a BRUKER
BT pH titrator. 550 lL of the sample were transferred to a 5 mm
NMR tube. The samples were continuously kept on ice between
steps.
1H NMR spectra were acquired on a Bruker AVIII-600 MHz NMR
spectrometer (Bruker Biospin, Switzerland) with a CPP-TCI probe.
Topspin 3.2pl5 (Bruker Biospin, Germany) was used for acquiring
H. Alipour, R.K. Duus, R. Wimmer et al. European Journal of Obstetrics & Gynecology and Reproductive Biology 264 (2021) 178–183spectra at 310.1 K. CPMG (T2 relaxation-edited Carr–Purcell–Mei
boom–Gill [26] (128 scans, 114940 complex data points, spectral
width of 23.94 ppm, acquisition time 4 s, relaxation delay 0.97 s.
Weak continuous wave irradiation (cB1/2p = 46.6 Hz) was used
for water suppression. The total spin-echo relaxation delay was
80.17 ms. This consisted of 130 repetitions of (s–p–s) sandwiches
(s = 0.3 ms and p is a 180 pulse of 16.7 ls. For the conformation
of metabolites, 1H–1H 2D-TOCSY (Total Correlation Spectroscopy)
with a 120 ms clean-TOCSY mixing sequence and a multiplicity-
edited 1H–13C HSQC (Heteronuclear Single Quantum Coherence)
spectra were recorded on selected samples.
Chenomx NMR suite 8.1 (Chenomx, Canada) was used for the
identification and quantification of metabolites. The methyl group
signals of TPS-d4 were used as internal concentration standard.
Apart from the built-in ChenomX library, the Human Metabolome
Database [8,27,28] was used to search for matching compounds
and verify resonance assignments.
Statistical analysis
Metabolite concentrations (mg/dl) are shown as medians (IQR).
The Shapiro–Wilk normality test was applied, and data with non-
normal distributions were corrected by natural logarithmic or
cubic-root transformation. A paired-samples t-test was used to
compare the metabolite concentrations and sperm motility results
of consecutive ejaculates from individual men. Semen volumes are
reported as medians (IQR) and compared using the ‘‘Wilcoxon
matched pairs” test as the transformations did not result in a nor-Table 1
Median and interquartile ranges (IQR) of semen volume, sperm concentration, total motile
percentage of sperm categorized based on progression (WHO 2010), using the SCA in
Progressive motile sperm) collected after 4–7 days (ejaculate 1) and 2 h (ejaculate 2) of
ejaculates.










Ejaculate 1 3.0 (2.4–3.8) 114 (76–169) 81 (45–122) 40 (28–
Ejaculate 2 1.8 (1.5–2.5) 60 (38–89) 43 (28–62) 33 (19–
P value <0.0001* <0.0001* <0.0001* <0.05*
Fig. 1. Typical within-subject comparison of NMR Spectra of Seminal plasma from eja
ejaculatory abstinence. (For interpretation of the references to colour in this figure lege
180mal distribution. The association between abstinence duration,
semen volume, sperm concentration, and metabolite concentra-
tions in the first and second ejaculates, and the changes of the
mentioned parameters between the first and second ejaculates
(Ej.2–Ej.1) were assessed using Spearman’s non-parametric corre-
lation. Statistical analyses were performed using MedCalc soft-
ware version 15.8 (MedCalc Software, Belgium).Results
Table 1 shows semen parameters for samples collected after 4–
7 days and 2 h of abstinence, and the main finding of this has been
published previously [22]. A typical within-subject comparison of
NMR spectra of seminal plasma from ejaculates collected after long
(4–7 days; blue spectra) and short (2 h; red spectra) ejaculatory
abstinence can be seen in Fig. 1. A total of 30 metabolites (16
Amino acids, four energy metabolites, and ten other metabolites)
were identified and quantified. Table 2 shows the concentrations,
absolute amounts, and absolute amounts per 106 spermatozoa (ab-
solute amounts/total sperm count) of the metabolites.
Among the 30 identified metabolites, pyruvate had a higher
concentration in samples obtained after short ejaculation-
abstinence, while fructose, acetate, choline, methanol, N-
acetylglucosamine, O-acetylcarnitine, uridine, and sn-glycero-3-
phosphocoline had lower concentrations. There was no difference
for the remaining 21 metabolites (Table 2). All metabolites showed
lower absolute amounts in the second ejaculate. Pyruvate and tau-sperm concentration, total sperm count (TSC), total motile sperm count (TMSC) and
samples (Immotile: Non-motile sperm, NPM: Non-progressive motile sperm; PM:








PM % NPM % Immotile %
56) 23 (15–40) 38 (20–54) 24 (21–30) 31 (22–52)
46) 23 (15–38) 47 (33–61) 25 (19–33) 26 (14–34)
0.31 <0.001* 0.831 <0.001*
culates collected after long (4–7 days; blue spectra) and short (2 h; red spectra)
nd, the reader is referred to the web version of this article.)
Table 2
Median and interquartile ranges (IQR) of concentrations [mg/dl] of seminal plasma metabolites (corresponding to a dilution factor of 6) identified by 1H-nuclear magnetic resonance spectroscopy, absolute amounts






(volume  metabolite concentration)
[mg]Median
(IQR)
Absolute amounts per 106 spermatozoa
(absolute amount/total sperm count)
[ng/106 spermatozoa]Median
(IQR)




Non-essential 1 Alanine 6.75 (4.88–8.44) 4.89 (3.63–6.07) 0.72 0.21 (0.12–0.24) 0.09 (0.07–0.14) <0.0001* 1,50 (1.09–2.79) 1.52 (0.90–3.33) 0.62
2 Arginine 8.55 (5.95–12.18) 6.39 (3.93–7.637) 0.75 0.26 (0.17–0.37) 0.10 (0.09–0.19) <0.0001* 2.18 (1.48–3.33) 1.96 (1.04–3.20) 0.26
3 Asparagine 9.94 (7.99–13.23) 7.15 (5.44–9.43) 0.72 0.31 (0.20–0.39) 0.13 (0.10–0.21) <0.0001* 2.13 (1.71–4.28) 2.39 (1.34–4.27) 0.54
4 Glutamate 22.15 (17.47–27.97) 16.33 (12.52–20.23) 0.74 0.68 (0.46–0.87) 0.31 (0.22–0.48) <0.0001* 5.39 (3.55–8.61) 4.92 (3.68–12.80) 0.69
5 Glutamine 18.14 (14.16–22.47) 13.94 (8.32–17.43) 0.77 0.51 (0.34–0.67) 0.22 (0.17–0.38) <0.0001* 4.35 (2.281–7.71) 4.06 (2.32–5.61) 0.62
6 Glycine 12.68 (8.54–18.10) 8.78 (5.83–12.30) 0.69 0.40 (0.26–0.51) 0.17 (0.13–0.23) <0.0001* 2.77 (2.17–5.80) 2.79 (1.60–6.92) 0.41
7 Proline 2.71 (1.73–3.75) 2.48 (1.10–3.25) 0.1 0.29 (0.19–0.39) 0.12 (0.09–0.20) 0.0002* 2.22 (1.69–4.17) 2.21 (1.28–4.06) 0.91
8 Serine 38.32 (28.51–52.91) 28.49 (21.88–37.12) 0.65 0.40 (0.26–0.56) 0.17 (0.12–0.29) <0.0001* 3.01 (2.19–5.31) 3.22 (1.77–5.51) 0.59
9 Tyrosine 13.03 (11.12–16.66) 9.78 (7.88–12.07) 0.61 0.28 (0.20–0.54) 0.15 (0.07–0.26) <0.0001* 2.33 (1.27–4.94) 2.49 (0.92–5.61) 0.42
Essential 10 Isoleucine 10.21 (7.89–12.45) 7.11 (4.73–8.88) 0.76 0.10 (0.07–0.14) 0.05 (0.03–0.08) <0.0001* 0.74 (0.57–1.25) 0.80 (0.51–1.51) 0.35
11 Leucine 14.29 (9.83–16.26) 9.25 (6.85–12.08) 0.92 0.08 (0.05–0.12) 0.05 (0.03–0.07) <0.0001* 0.61 (0.45–1.11) 0.61 (0.30–1.60) 0.90
12 Phenylalanine 3.51 (2.87–4.32) 2.68 (2.04–3.22) 0.74 1.19 (0.76–1.62) 0.52 (0.37–0.85) <0.0001* 8.63 (6.58–16.60) 9.04 (5.95–16.2) 0.79
13 Threonine 7.63 (6.59–10.05) 5.03 (3.01–6.90) 0.66 0.22 (0.16–0.30) 0.08 (0.06–0.16) <0.0001* 1.76 (1.22–3.18) 1.50 (0.86–3.85) 0.19
14 Tryptophan 0.22 (0.17–0.36) 0.18 (0.15–0.42) 0.83 0.01 (0.01–0.02) 0.01 (0.00–0.01) <0.0001* 0.06 (0.04–0.13) 0.08 (0.03–0.31) 0.19
15 Lysine 9.99 (5.87–18.05) 6.05 (4.26–11.69) 0.75 0.37 (0.27–0.53) 0.19 (0.12–0.28) <0.0001* 3.20 (2.21–5.04) 3.24 (1.96–10.40) 0.14
16 Valine 10.53 (7.93–13.77) 7.26 (4.73–9.87) 0.69 0.32 (0.20–0.41) 0.13 (0.09–0.19) <0.0001* 2.34 (1.71–4.33) 2.03 (1.18–5.05) 0.31
Energy metabolites 17 Fructose 44.95 (32.66–51.51) 34.15 (27.68–46.44) <0.05* 1.44 (0.80–1.76) 0.73 (0.42–1.15) <0.0001* 12.2 (6.84–16.90) 12.90 (6.87–17.70) 0.63
18 Galactose 0.96 (0.70–1.23) 0.92 (0.55–1.20) 0.16 0.03 (0.02–0.04) 0.02 (0.01–0.03) <0.0001* 0.24 (0.13–0.47) 0.26 (0.17–0.73) 0.16
19 Lactate 12.24 (9.57–17.49) 10.65 (9.35–15.23) 0.42 0.33 (0.24–0.56) 0.24 (0.17–0.30) <0.0001* 3.34 (2.65–4.49) 3.86 (2.40–5.69) 0.06
20 Pyruvate 5.24 (3.92–6.71) 7.05 (5.11–9.14) <0.001* 0.14 (0.10–0.21) 0.13 (0.06–0.21) <0.0288* 1.29 (0.83–2.62) 1.92 (1.12–3.87) <0.001*
Other
metabolites
21 Acetate 1.73 (1.49–2.29) 1.65 (1.15–2.19) <0.01* 0.05 (0.04–0.09) 0.03 (0.02–0.05) <0.0001* 0.48 (0.34–0.81) 0.53 (0.35–0.95) 0.66
22 Choline 53.27 (40.82–64.32) 45.1 (32.80–59.79) <0.01* 1.76 (1.06–2.43) 0.89 (0.57–1.42) <0.0001* 14.8 (8.91–25.00) 14.4 (9.02–23.60) 0.68
23 Citrate 29.29 (21.33–36.40) 24.29 (18.74–33.74) 0.08 0.82 (0.66–1.09) 0.49 (0.35–0.71) <0.0001* 7.13 (4.52–12.00) 9.23 (4.51–19.6) 0.08
24 Formate 0.08 (0.068–0.10) 0.08 (0.07–0.10) 0.49 [0.24 (0.16–0.33)] *10-2 [0.16 (0.10–0.21)] *10-2 <0.0001* 0.02 (0.01–0.03) 0.03 (0.02–0.04) 0.05
25 Methanol 0.81 (0.67–1.26) 0.76 (0.51–1.03) <0.001* 0.03 (0.02–0.04) 0.01 (0.01–0.02) <0.0001* 0.25 (0.16–0.42) 0.22 (0.14–0.50) 0.73
26 N-Acetylglucosamine 5.64 (4.66–7.35) 4.95 (3.25–6.65) <0.01* 0.18 (0.13–0.25) 0.09 (0.06–0.15) <0.0001* 1.34 (0.91–2.42) 1.43 (0.85–2.85) 0.86
27 O-Acetylcarnitine 0.54 (0.42–1.01) 0.49 (0.39–0.79) <0.05* 0.02 (0.01–0.03) 0.01 (0.01–0.02) <0.0001* 0.15 (0.10–0.31) 0.18 (0.10–0.33) 0.23
28 Taurine 1.59 (1.41–2.19) 1.58 (1.27–2.37) 0.39 0.05 (0.04–0.08) 0.03 (0.02–0.05) <0.0001* 0.43 (0.28–0.95) 0.58 (0.36–0.92) <0.05*
29 Uridine 3.91 (3.40–4.77) 3.69 (2.44–4.29) <0.01* 0.11 (0.08–0.15) 0.07 (0.04–0.10) <0.0001* 0.95 (0.65–1.77) 0.97 (0.59–1.97) 0.75
30 sn-Glycero-3-
phosphocholine
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this measure was lower for all other metabolites (Table 2). Multi-
variate statistics (PCA and PLDSA) did not provide satisfying results
and are therefore not included.Discussion
To the best of our knowledge, this is the first study describing
the intra-individual differences in metabolomics profiles in HSP
of normozoospermic men after short and long abstinence periods.
The identified metabolite variations coincided with higher per-
centages of motile spermatozoa in ejaculates obtained after the
short abstinence [22,29,30]. To which degree these associations
reflect causality remains to be shown. Nevertheless, the longer
duration of spermatogenesis [31] than the abstinence periods
assessed in this study and the lack of any evident variation in mor-
phology between the two samples suggests that the observed dif-
ference in quality between the two ejaculates was not associated
with spermatogenesis and maturation processes, but possibly with
the composition of HSP. It also makes it safe to assume that the
percentage of immature sperm was not increased with shorter
abstinence.
The metabolomic composition of the HSP is influenced by secre-
tions from the prostate, seminal vesicles, epididymides, testes, bul-
bourethral and periurethral glands [4,5]. The amino acids in human
HSP mainly originate from the testes or epididymides [32] and
partly from the proteolytic activity in the semen after ejaculation
[33]. Whether metabolite concentrations in the HSP are biologi-
cally controlled by a capacity not related to the abstinence period
remains unknown. Nevertheless, the decreased concentration of all
identified metabolites after the short abstinence period (although
insignificant) could be related to insufficient time (2 h) for the col-
lection and secretion of the metabolites by the accessory glands or
a shorter period of the proteolytic activity before ejaculation,
rather than a change in metabolic pathways. Additional investiga-
tions are required to confirm this hypothesis.
A recent meta-analysis revealed that shorter abstinence
resulted in higher fertilization rates (P = 0.09) and significantly
higher implantation (P = 0.0001) and pregnancy rates (p = 0.006)
following fresh embryo transfer cycles for patients undertaking
ART [34]. It can be speculated that modest changes in the HSP com-
position may have affected the spermatozoa motility and kine-
matic parameters.
Animal studies showed pyruvate and lactate as the most impor-
tant energy sources for sperm mitochondrial function and motility
[35]. Human spermatozoa presented increased intracellular ATP
levels, progressive motility and hyperactivation (56, 21 and 130%,
respectively) when supplemented with exogenic pyruvate [36].
Despite the lower concentrations of pyruvate and lactate, in the
HSP of the second ejaculates, the lower total number of spermato-
zoa resulted in higher absolute amounts of these energy metabo-
lites per spermatozoa, which may potentially explain the better
motility characteristics observed in the second ejaculates. The pro-
tective effect of pyruvate against oxidative stress previously shown
in somatic cells [37,38] and sperm of cyclophosphamide-treated
mice [39] may have also played a role towards the better quality
of the sperm in the second ejaculates.
Taurine is an essential amino acid that is not grouped with the
other amino acids since it is not a protein building block [8]. The
exact origin of taurine in human semen is unclear, but animal stud-
ies suggest an epididymal origin [40]. Taurine is important as a
capacitating agent [41,42] and a sperm motility factor [43,44] with
antioxidative and membrane-stabilizing effects [21,44-47]. Low
taurine levels in seminal plasma and sperm have been suggested
as markers of male factor infertility [47]. Thus, the observed higher182level of taurine per spermatozoa might have also had a role in the
better Motility of the sperm in the second ejaculates.
Limitations and strengths
Untargeted NMR metabolomics offers the advantage of an unbi-
ased global analysis of all small molecules in a given body fluid.
The study is thus not limited to a set of predefined metabolites
tested for, but every metabolite present above a certain concentra-
tion threshold can be identified and quantified. At the same time,
sample preparation and pretreatment are minimal for NMR inves-
tigations. The weakness of the NMR method is the rather high
metabolite concentrations required. Metabolites present at con-
centrations <20 lM are likely not detectable with our experimental
setup, and even metabolites present at higher concentrations can
easily be missed if their resonances are obscured by resonances
of metabolites present in higher concentrations.
Missing somemetabolites, such as Histidine, methionine, aspar-
tic acid (aspartate), and cysteine that had been identified in the
HSP by previous studies [49,50], could be due to technical issues
regarding the procedure of identifying the many extensively over-
lapping resonances in a single pulse spectra produced by untar-
geted whole seminal fluid 1H NMR [48]. It is also possible that
essential amino acids originating from the diet are not present in
the accessory sex glands, while non-essential amino acids are
absorbed in the epididymis or not even synthesized by the acces-
sory sex glands. Nevertheless, the reason why some metabolites
were not identified remains debatable.
It has to be kept in mind that the possible elemental exchange
between HSP and sperm cells, possibly impacted by sperm concen-
tration, may also be a co-factor complicating the interpretation of
the metabolite measurements [49]. Further studies eliminating the
possible effect of sperm metabolism after ejaculation and during
liquefaction time can exclude some confounding factors and deli-
ver a better explanation for the underlying mechanism of changes
in the metabolites concentrations and its effect on sperm quality in
consecutive ejaculates. Ensuring the lack of contamination of HSP
with cell debris by filtration of the HSP after centrifugation [50]
could also assure more precise results in future studies.Conclusion
Nuclear Magnetic Resonance Spectroscopy detected lower con-
centrations of seminal plasma metabolites except for pyruvate in
ejaculates collected after short abstinence periods, which may be
related to the shorter time available for the secretion and collec-
tion of these metabolites by the accessory glands. However, the
concomitant lower sperm concentration in the second ejaculate
resulted in increased absolute amounts of pyruvate and taurine
per spermatozoa, accompanied by better sperm motility in these
samples. The reported metabolite concentrations may be used as
interim reference values for short and long abstinence periods
and comparison by future studies. Further investigation on the
complex composition of the metabolites in the seminal plasma
and their possible effect on sperm function is required before a def-
inite conclusion regarding a potential causality between HSP
metabolite concentrations, and sperm quality can be reached.Study funding and competing interest(s)
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